Screener
Hinge Health HNGE Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Hinge Health in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Hinge Health’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054327
FAQ
- What is Hinge Health's cash & equivalents?
- Hinge Health (HNGE) reported cash & equivalents of $287.67M in Q2 2026.
- How has Hinge Health's cash & equivalents changed year-over-year?
- Hinge Health's cash & equivalents increased by 20.4% year-over-year, from $238.97M to $287.67M.
- What is the long-term trend for Hinge Health's cash & equivalents?
- Over 2 years (2023 to 2025), Hinge Health's cash & equivalents has grown at a -5.5% compound annual growth rate (CAGR), from $234.95M to $209.8M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Hinge Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude